Cargando…
High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration
PURPOSE: High-density lipoproteins (HDL) have long been implicated in the pathogenesis of age-related macular degeneration (AMD). However, conflicting results have been reported with regard to the associations of AMD with HDL-cholesterol levels. The present study is the first to assess HDL compositi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865135/ https://www.ncbi.nlm.nih.gov/pubmed/27171197 http://dx.doi.org/10.1371/journal.pone.0154397 |
_version_ | 1782431736472272896 |
---|---|
author | Pertl, Laura Kern, Sabine Weger, Martin Hausberger, Silke Trieb, Markus Gasser-Steiner, Vanessa Haas, Anton Scharnagl, Hubert Heinemann, Akos Marsche, Gunther |
author_facet | Pertl, Laura Kern, Sabine Weger, Martin Hausberger, Silke Trieb, Markus Gasser-Steiner, Vanessa Haas, Anton Scharnagl, Hubert Heinemann, Akos Marsche, Gunther |
author_sort | Pertl, Laura |
collection | PubMed |
description | PURPOSE: High-density lipoproteins (HDL) have long been implicated in the pathogenesis of age-related macular degeneration (AMD). However, conflicting results have been reported with regard to the associations of AMD with HDL-cholesterol levels. The present study is the first to assess HDL composition and metrics of HDL function in patients with exudative AMD and control patients. METHODS: Blood samples were collected from 29 patients with exudative AMD and 26 age-matched control patients. Major HDL associated apolipoproteins were determined in apoB-depleted serum by immunoturbidimetry or ELISA, HDL-associated lipids were quantified enzymatically. To get an integrated measure of HDL quantity and quality, we assessed several metrics of HDL function, including cholesterol efflux capacity, anti-oxidative and anti-inflammatory activities using apoB-depleted serum from study participants. RESULTS: In our study, we observed that the HDL associated acute phase protein serum amyloid A (SAA) was significantly increased in AMD patients (p<0.01), whereas all other assessed apolipoproteins including ApoA-I, apoA-II, apoC-II, apoC-III and apoE as well as major HDL associated lipids were not altered. HDL efflux capacity, anti-oxidative capacity and arylesterase activity were not different in AMD patients when compared with the control group. The ability of apoB-depleted serum to inhibit monocyte NF-κB expression was significantly improved in AMD patients (mean difference (MD) -5.6, p<0.01). Moreover, lipoprotein-associated phospholipase A2 activity, a marker of vascular inflammation, was decreased in AMD subjects (MD -24.1, p<0.01). CONCLUSIONS: The investigated metrics of HDL composition and HDL function were not associated with exudative AMD in this study, despite an increased content of HDL associated SAA in AMD patients. Unexpectedly, anti-inflammatory activity of apoB-depleted serum was even increased in our study. Our data suggest that the investigated parameters of serum HDL function showed no significant association with exudative AMD. However, we cannot exclude that alterations in locally produced HDL may be part of the AMD pathogenesis. |
format | Online Article Text |
id | pubmed-4865135 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-48651352016-05-26 High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration Pertl, Laura Kern, Sabine Weger, Martin Hausberger, Silke Trieb, Markus Gasser-Steiner, Vanessa Haas, Anton Scharnagl, Hubert Heinemann, Akos Marsche, Gunther PLoS One Research Article PURPOSE: High-density lipoproteins (HDL) have long been implicated in the pathogenesis of age-related macular degeneration (AMD). However, conflicting results have been reported with regard to the associations of AMD with HDL-cholesterol levels. The present study is the first to assess HDL composition and metrics of HDL function in patients with exudative AMD and control patients. METHODS: Blood samples were collected from 29 patients with exudative AMD and 26 age-matched control patients. Major HDL associated apolipoproteins were determined in apoB-depleted serum by immunoturbidimetry or ELISA, HDL-associated lipids were quantified enzymatically. To get an integrated measure of HDL quantity and quality, we assessed several metrics of HDL function, including cholesterol efflux capacity, anti-oxidative and anti-inflammatory activities using apoB-depleted serum from study participants. RESULTS: In our study, we observed that the HDL associated acute phase protein serum amyloid A (SAA) was significantly increased in AMD patients (p<0.01), whereas all other assessed apolipoproteins including ApoA-I, apoA-II, apoC-II, apoC-III and apoE as well as major HDL associated lipids were not altered. HDL efflux capacity, anti-oxidative capacity and arylesterase activity were not different in AMD patients when compared with the control group. The ability of apoB-depleted serum to inhibit monocyte NF-κB expression was significantly improved in AMD patients (mean difference (MD) -5.6, p<0.01). Moreover, lipoprotein-associated phospholipase A2 activity, a marker of vascular inflammation, was decreased in AMD subjects (MD -24.1, p<0.01). CONCLUSIONS: The investigated metrics of HDL composition and HDL function were not associated with exudative AMD in this study, despite an increased content of HDL associated SAA in AMD patients. Unexpectedly, anti-inflammatory activity of apoB-depleted serum was even increased in our study. Our data suggest that the investigated parameters of serum HDL function showed no significant association with exudative AMD. However, we cannot exclude that alterations in locally produced HDL may be part of the AMD pathogenesis. Public Library of Science 2016-05-12 /pmc/articles/PMC4865135/ /pubmed/27171197 http://dx.doi.org/10.1371/journal.pone.0154397 Text en © 2016 Pertl et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Pertl, Laura Kern, Sabine Weger, Martin Hausberger, Silke Trieb, Markus Gasser-Steiner, Vanessa Haas, Anton Scharnagl, Hubert Heinemann, Akos Marsche, Gunther High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration |
title | High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration |
title_full | High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration |
title_fullStr | High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration |
title_full_unstemmed | High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration |
title_short | High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration |
title_sort | high-density lipoprotein function in exudative age-related macular degeneration |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865135/ https://www.ncbi.nlm.nih.gov/pubmed/27171197 http://dx.doi.org/10.1371/journal.pone.0154397 |
work_keys_str_mv | AT pertllaura highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration AT kernsabine highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration AT wegermartin highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration AT hausbergersilke highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration AT triebmarkus highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration AT gassersteinervanessa highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration AT haasanton highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration AT scharnaglhubert highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration AT heinemannakos highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration AT marschegunther highdensitylipoproteinfunctioninexudativeagerelatedmaculardegeneration |